Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution
Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution
The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years.
The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years.
Pharma Giant Expands with Strategic Acquisition in Singapore
The company has a strong presence in regulated markets such as the United States and Europe and is a leading producer of niche generic formulations.
The company has been actively expanding its product pipeline, with over 70 commercialized products and a healthy pipeline of 100+ approved products.
42.4% Returns From 52-Week Low: Pharma Stock Under Rs 75 Jumps 19.9%; Do You Own It?
The company has a market cap of over Rs 380 crore and the stock is up by 42.4 per cent from its 52-week low of Rs 50.42 per share.
The company has a market cap of over Rs 380 crore and the stock is up by 42.4 per cent from its 52-week low of Rs 50.42 per share.
Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares
The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share.
The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share.
Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary
The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share.
The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share.
Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC
The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share.
The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent.
Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000
The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE.
The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE.
Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC
The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent.
The stock is up 34.21 per cent from its 52-week low of Rs 38.01 per share.
Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries
The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent.
The stock is up 30 per cent from its 52-week low of Rs 37.50 per share.
230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it?
The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years.
The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent.
This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States!
The company holds a leadership position in cardiovascular, anti-diabetic and respiratory segments and is the third-largest pharmaceutical company in the U.S. by prescriptions.
A global pharmaceutical company, has announced the launch of Thiamine Hydrochloride Injection USP, following the approval of its alliance partner Caplin Steriles Limited's ANDA by the U.S. FDA.
Biggest IPO of 2023 gets listed; stock surges 31.86 per cent from issue price
IPO listed with a 20.37 per cent premium on the BSE!
IPO listed with a 20.37 per cent premium on the BSE!